{"title":"Ralph A. Bradshaw: Scholar, leader, entrepreneur","authors":"Philip D. Stahl","doi":"10.1096/fba.2022-00088","DOIUrl":null,"url":null,"abstract":"<p>Ralph Bradshaw, sage colleague, entrepreneur, gifted editor, and prescient scientist, recently stepped down as the Editor in Chief of <i>FASEB BioAdvances</i>. This presents the opportunity to pause and reflect on the career of an extraordinary individual, whose continuing commitment to science, science publishing, and the scholarly societies that represent and advocate for us all, illustrates the exceptional. Ralph's career reflects an unyielding dedication to those goals that we all strive to achieve—scholarship with high standards, leadership, service, and entrepreneurship.</p><p>Ralph grew up in the Boston area and attended Colby College, where he majored in chemistry; he completed his doctorate with Robert Hill in the Biochemistry Department at Duke, where his thesis work focused on protein chemistry. His postdoctoral work at Indiana University in the laboratory of Frank Gurd and the University of Washington in the laboratory of Hans Neurath allowed him to refine his repertoire of protein sequencing and analytic methodologies. P. Roy Vagelos (former CEO of Merck and former department head at Washington University) recruited Ralph to the Department of Biological Chemistry at Washington University as Roy began a highly successful renovation and rebuilding of the department after the long reign of Carl Cori. This is where I first met Ralph, as we were newly appointed assistant professors in biochemistry and physiology, respectively, and shared our interest in graduate education.</p><p>In 1973, Vagelos and colleagues at Washington University advanced a novel approach to graduate education in the biological and biomedical sciences, the Division of Biology and Biomedical Sciences (DBBS)—recently named the Roy and Diana Vagelos Division of Biology and Biomedical Sciences. The idea was based on the ongoing diversification of medical and biological research, where the traditional departmental boundaries that separated disparate “fields of research” were increasingly seen as hardened silos that suppressed innovation and reduced opportunities for graduate research. By creating programs built on common faculty interests rather than departmental affiliation, cross disciplinary opportunities for graduate research flourished—this approach in one form or another is now common among nearly all research institutions. Ralph Bradshaw played a key role in getting the DBBS off the ground—perhaps a precursor to his now well appreciated organizational skills. He was appointed the first chair of the newly formed graduate admissions committee, an enthusiastic recruiter of talented students to the programs and the principal investigator on one of the first NIH training grants under this new umbrella. Roy Vagelos commented, “Bradshaw was an enthusiastic and very effective recruiter of graduate students to Washington University. When the DBBS faculty decided that the University should have greater diversity among its graduate students, Ralph led a small group of faculty who visited historically black colleges to recruit top students to join the graduate programs of Washington University.”</p><p>Ralph was and is an inveterate keeper of data and how it is organized, a master of the Excel sheet. Shortly after returning from a sabbatical in Australia, Ralph assembled a collage in his home study, where we hosted aspiring applicants to the program. The collage included dozens of memorabilia from his travels neatly arranged in order. I had just returned from a trip to the United Kingdom, and I had a train ticket stub in my pocket, which, as a joke, I slipped behind one of the items on Ralph's collage. Wouldn't you know it, but first thing the next morning, I got a telephone call: “Stahl, why are you messing with my (bleep) board?” Obviously, this man has an eye for order that carries throughout his life, his various collections of books and memorabilia, on through to his research and his editorial work.</p><p>Ralph has been an “includer,” striving to enhance representation of historically excluded groups, bringing scientists together to enhance collegiality, serving as an officer of multiple scientific societies and organizations. Here is a quote from Amy Bradshaw (Professor of Cell Biology at the Medical University of South Carolina): “Growing up, our house had many visitors from all over the world, which allowed me to see and appreciate the wonder of different perspectives—an ideal reinforced and practiced by both my parents. One fond childhood memory I have is our annual Thanksgiving feast. At Ralph and Penny's, we often had a large gathering. As many people in the department were international, there were frequently guests who had never heard of Thanksgiving or had only a vague notion of this American tradition. My mom would make an enormous turkey, and everyone would bring dishes from all over the world to complete the meal. I would be in charge of making place cards so that my father could arrange the seating around the “table,” which usually consisted of many tables pushed together. At an early age, I saw the diversity of people that science brings together. That science (and a love for good food) provides a common thread that most often comes with respect and acceptance for our differences, was a gem of a life lesson that I learned around that big Thanksgiving Day table.”</p><p>In 1982, Ralph moved to take up the Chair of Biological Chemistry at the University of California, Irvine, where he built a strong department recruiting new faculty to the program. During this time, Ralph made seminal discoveries through the sequencing, characterization, and functional elucidation of many essential proteins involved in cell signaling. His work on epidermal growth factor (EGF) and its prototypical signaling receptor, is exemplar. At that time, polypeptide growth factor camps were still divided between mitogenic versus neurotrophic growth factors, and Ralph's work broke these artificial walls by showing that mitogenic growth factors could in fact act as neurotrophic factors (and vice-versa) depending on the cellular context and receptor involved. The signaling of neurotrophic factors in neuronal cells was also extensively deciphered by a combination of complementary methodological approaches. The Bradshaw lab became an internationally respected and inspiring reference in the field of cell signaling.</p><p>Hubert Hondermarck (Professor of Biochemistry, University of Newcastle, Callaghan, NSW, Australia) remarked, “Ralph Bradshaw was also among the few pioneers of the field of proteomics. Not only did he publish germane papers in the field, particularly in relation to cell signaling, and organize many international meetings, but his role was particularly determinant through the launch of the reference journal in the field: <i>Molecular and Cellular Proteomics</i> (<i>MCP</i>). The then emerging field of proteomics needed a flagship journal with high standards for publication of high-quality proteomic data, and with his natural scientific rigor and energy, Ralph (together with Al Burlingame from the University of California, San Francisco) provided exactly that. It should be noticed that his guidelines for proteomic data publication are still the reference today and they have been implemented by most leading journals in life science.”</p><p>Ralph's interest in the general welfare of biomedical research led him to hold membership on no fewer than 22 editorial boards, including Editor in Chief of <i>Trends in Biochemical Sciences</i>, <i>Molecular Cell Biology Research Communications</i>, and <i>FASEB BioAdvances</i>. As mentioned above, Ralph served as founding editor of <i>MCP</i> and was an early supporter of the Keystone Symposia, as well as a founder and former president of The Protein Society. Among all of these various and overlapping activities, Ralph played a key role in the evolution and success of the Federation of American Societies for Experimental Biology (FASEB). Judy Bond (Professor of Biochemistry Emerita, Pennsylvania State University) writes, “Ralph has been a leader, a consensus builder, and extraordinary contributor to FASEB for over three decades. In the 1990s, he led Federal Funding Conferences that were influential in setting annual increases to biomedical agencies (e.g., NIH, NSF), and participated in these conferences for many years. He was part of the leadership of FASEB that organized a meeting of academic and industry leaders with members of the US House of Representatives that led to the doubling of the NIH budget over a 5-year period, a substantial achievement for biomedical research! During his presidency of FASEB (1995) and beyond, he continued to enhance relations with members of Congress and was a fierce advocate of bipartisan support for biomedical research. He organized a consensus conference in 1996 that brought together a coalition of 40 biomedical organizations to advocate for the reasonable and responsible regulation of scientific misconduct, and agree on the identification of fabrication, falsification, and plagiarism as misconduct activities. He played a continuous influential role in the extraordinary growth of the Federation in the 21st century, and he became engaged in delving into the history of the organization. Ralph was the inspiration, creator, and author of the book documenting the history of the Federation, <i>The Federation of American Societies for Experimental Biology: A Century of Service and Advocacy</i> (Bethesda, MD: FASEB, 2019). The book documents in detail the growth, growing pains, accomplishments, and legacy of the Federation from its founding in 1912 to 2017. His tireless efforts on behalf of FASEB continued in the last few years as he served on the Board of Directors representing the US Human Proteome Organization, chaired a Task Force on Governance for the Future of FASEB, and served as Editor-in-Chief of <i>FASEB BioAdvances</i>.”</p><p>Ken Thomas (Cofounder and Advisor at Trefoil Therapeutics, San Diego, CA, USA) writes, “In addition to Ralph's numerous academic achievements and contributions, he has been actively involved in applying his extensive scientific expertise and perspective in protein biochemistry as an industrial consultant and member of corporate Scientific Advisory Boards, many of which he has chaired. Notably, he also has cofounded several companies, recently including, along with three of his former students, Trefoil Therapeutics, a clinical stage biotechnology company arising from early work in his lab on the discovery of the protein growth factor FGF-1. Ralph has remained intimately involved in the development of Trefoil, serving as Chief Scientific Officer and currently as Scientific Advisory Board Chair. He has approached these entrepreneurial activities with integrity, knowledgeable insights, and enthusiasm, making working with him a consistently rewarding and enjoyable experience, not only as a cofounder but also an independent scientific collaborator and originally a postdoctoral fellow.”</p><p>Ralph Bradshaw, scientist, teacher, editor, and entrepreneur, is one of a group of individuals, scientists, and physician-scientists, educated in the 1960s before entering the academy in the 1970s, who have helped transform and advance American life sciences to levels unanticipated even by the most sanguine observer. This group of individuals has contributed to and supported graduate and medical education; they have been key drivers of the expansion of our basic understanding of molecular processes in cells and organisms; they have widely contributed to the quality and mode of communication that links scientists and their communities with the public; and they have catalyzed the transfer of basic science to the applied arena, from bench to bedside. These attributions are reflected in the careers of this group of senior scientists. Now aging, some of this cohort have excelled in one or more of these areas of excellence. A smaller number have made their mark in all of the above. This is the category that represents the contributions by Ralph Bradshaw, for which we owe a significant debt of gratitude and admiration.</p>","PeriodicalId":12093,"journal":{"name":"FASEB bioAdvances","volume":"4 11","pages":"691-693"},"PeriodicalIF":2.5000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635006/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FASEB bioAdvances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1096/fba.2022-00088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Ralph Bradshaw, sage colleague, entrepreneur, gifted editor, and prescient scientist, recently stepped down as the Editor in Chief of FASEB BioAdvances. This presents the opportunity to pause and reflect on the career of an extraordinary individual, whose continuing commitment to science, science publishing, and the scholarly societies that represent and advocate for us all, illustrates the exceptional. Ralph's career reflects an unyielding dedication to those goals that we all strive to achieve—scholarship with high standards, leadership, service, and entrepreneurship.
Ralph grew up in the Boston area and attended Colby College, where he majored in chemistry; he completed his doctorate with Robert Hill in the Biochemistry Department at Duke, where his thesis work focused on protein chemistry. His postdoctoral work at Indiana University in the laboratory of Frank Gurd and the University of Washington in the laboratory of Hans Neurath allowed him to refine his repertoire of protein sequencing and analytic methodologies. P. Roy Vagelos (former CEO of Merck and former department head at Washington University) recruited Ralph to the Department of Biological Chemistry at Washington University as Roy began a highly successful renovation and rebuilding of the department after the long reign of Carl Cori. This is where I first met Ralph, as we were newly appointed assistant professors in biochemistry and physiology, respectively, and shared our interest in graduate education.
In 1973, Vagelos and colleagues at Washington University advanced a novel approach to graduate education in the biological and biomedical sciences, the Division of Biology and Biomedical Sciences (DBBS)—recently named the Roy and Diana Vagelos Division of Biology and Biomedical Sciences. The idea was based on the ongoing diversification of medical and biological research, where the traditional departmental boundaries that separated disparate “fields of research” were increasingly seen as hardened silos that suppressed innovation and reduced opportunities for graduate research. By creating programs built on common faculty interests rather than departmental affiliation, cross disciplinary opportunities for graduate research flourished—this approach in one form or another is now common among nearly all research institutions. Ralph Bradshaw played a key role in getting the DBBS off the ground—perhaps a precursor to his now well appreciated organizational skills. He was appointed the first chair of the newly formed graduate admissions committee, an enthusiastic recruiter of talented students to the programs and the principal investigator on one of the first NIH training grants under this new umbrella. Roy Vagelos commented, “Bradshaw was an enthusiastic and very effective recruiter of graduate students to Washington University. When the DBBS faculty decided that the University should have greater diversity among its graduate students, Ralph led a small group of faculty who visited historically black colleges to recruit top students to join the graduate programs of Washington University.”
Ralph was and is an inveterate keeper of data and how it is organized, a master of the Excel sheet. Shortly after returning from a sabbatical in Australia, Ralph assembled a collage in his home study, where we hosted aspiring applicants to the program. The collage included dozens of memorabilia from his travels neatly arranged in order. I had just returned from a trip to the United Kingdom, and I had a train ticket stub in my pocket, which, as a joke, I slipped behind one of the items on Ralph's collage. Wouldn't you know it, but first thing the next morning, I got a telephone call: “Stahl, why are you messing with my (bleep) board?” Obviously, this man has an eye for order that carries throughout his life, his various collections of books and memorabilia, on through to his research and his editorial work.
Ralph has been an “includer,” striving to enhance representation of historically excluded groups, bringing scientists together to enhance collegiality, serving as an officer of multiple scientific societies and organizations. Here is a quote from Amy Bradshaw (Professor of Cell Biology at the Medical University of South Carolina): “Growing up, our house had many visitors from all over the world, which allowed me to see and appreciate the wonder of different perspectives—an ideal reinforced and practiced by both my parents. One fond childhood memory I have is our annual Thanksgiving feast. At Ralph and Penny's, we often had a large gathering. As many people in the department were international, there were frequently guests who had never heard of Thanksgiving or had only a vague notion of this American tradition. My mom would make an enormous turkey, and everyone would bring dishes from all over the world to complete the meal. I would be in charge of making place cards so that my father could arrange the seating around the “table,” which usually consisted of many tables pushed together. At an early age, I saw the diversity of people that science brings together. That science (and a love for good food) provides a common thread that most often comes with respect and acceptance for our differences, was a gem of a life lesson that I learned around that big Thanksgiving Day table.”
In 1982, Ralph moved to take up the Chair of Biological Chemistry at the University of California, Irvine, where he built a strong department recruiting new faculty to the program. During this time, Ralph made seminal discoveries through the sequencing, characterization, and functional elucidation of many essential proteins involved in cell signaling. His work on epidermal growth factor (EGF) and its prototypical signaling receptor, is exemplar. At that time, polypeptide growth factor camps were still divided between mitogenic versus neurotrophic growth factors, and Ralph's work broke these artificial walls by showing that mitogenic growth factors could in fact act as neurotrophic factors (and vice-versa) depending on the cellular context and receptor involved. The signaling of neurotrophic factors in neuronal cells was also extensively deciphered by a combination of complementary methodological approaches. The Bradshaw lab became an internationally respected and inspiring reference in the field of cell signaling.
Hubert Hondermarck (Professor of Biochemistry, University of Newcastle, Callaghan, NSW, Australia) remarked, “Ralph Bradshaw was also among the few pioneers of the field of proteomics. Not only did he publish germane papers in the field, particularly in relation to cell signaling, and organize many international meetings, but his role was particularly determinant through the launch of the reference journal in the field: Molecular and Cellular Proteomics (MCP). The then emerging field of proteomics needed a flagship journal with high standards for publication of high-quality proteomic data, and with his natural scientific rigor and energy, Ralph (together with Al Burlingame from the University of California, San Francisco) provided exactly that. It should be noticed that his guidelines for proteomic data publication are still the reference today and they have been implemented by most leading journals in life science.”
Ralph's interest in the general welfare of biomedical research led him to hold membership on no fewer than 22 editorial boards, including Editor in Chief of Trends in Biochemical Sciences, Molecular Cell Biology Research Communications, and FASEB BioAdvances. As mentioned above, Ralph served as founding editor of MCP and was an early supporter of the Keystone Symposia, as well as a founder and former president of The Protein Society. Among all of these various and overlapping activities, Ralph played a key role in the evolution and success of the Federation of American Societies for Experimental Biology (FASEB). Judy Bond (Professor of Biochemistry Emerita, Pennsylvania State University) writes, “Ralph has been a leader, a consensus builder, and extraordinary contributor to FASEB for over three decades. In the 1990s, he led Federal Funding Conferences that were influential in setting annual increases to biomedical agencies (e.g., NIH, NSF), and participated in these conferences for many years. He was part of the leadership of FASEB that organized a meeting of academic and industry leaders with members of the US House of Representatives that led to the doubling of the NIH budget over a 5-year period, a substantial achievement for biomedical research! During his presidency of FASEB (1995) and beyond, he continued to enhance relations with members of Congress and was a fierce advocate of bipartisan support for biomedical research. He organized a consensus conference in 1996 that brought together a coalition of 40 biomedical organizations to advocate for the reasonable and responsible regulation of scientific misconduct, and agree on the identification of fabrication, falsification, and plagiarism as misconduct activities. He played a continuous influential role in the extraordinary growth of the Federation in the 21st century, and he became engaged in delving into the history of the organization. Ralph was the inspiration, creator, and author of the book documenting the history of the Federation, The Federation of American Societies for Experimental Biology: A Century of Service and Advocacy (Bethesda, MD: FASEB, 2019). The book documents in detail the growth, growing pains, accomplishments, and legacy of the Federation from its founding in 1912 to 2017. His tireless efforts on behalf of FASEB continued in the last few years as he served on the Board of Directors representing the US Human Proteome Organization, chaired a Task Force on Governance for the Future of FASEB, and served as Editor-in-Chief of FASEB BioAdvances.”
Ken Thomas (Cofounder and Advisor at Trefoil Therapeutics, San Diego, CA, USA) writes, “In addition to Ralph's numerous academic achievements and contributions, he has been actively involved in applying his extensive scientific expertise and perspective in protein biochemistry as an industrial consultant and member of corporate Scientific Advisory Boards, many of which he has chaired. Notably, he also has cofounded several companies, recently including, along with three of his former students, Trefoil Therapeutics, a clinical stage biotechnology company arising from early work in his lab on the discovery of the protein growth factor FGF-1. Ralph has remained intimately involved in the development of Trefoil, serving as Chief Scientific Officer and currently as Scientific Advisory Board Chair. He has approached these entrepreneurial activities with integrity, knowledgeable insights, and enthusiasm, making working with him a consistently rewarding and enjoyable experience, not only as a cofounder but also an independent scientific collaborator and originally a postdoctoral fellow.”
Ralph Bradshaw, scientist, teacher, editor, and entrepreneur, is one of a group of individuals, scientists, and physician-scientists, educated in the 1960s before entering the academy in the 1970s, who have helped transform and advance American life sciences to levels unanticipated even by the most sanguine observer. This group of individuals has contributed to and supported graduate and medical education; they have been key drivers of the expansion of our basic understanding of molecular processes in cells and organisms; they have widely contributed to the quality and mode of communication that links scientists and their communities with the public; and they have catalyzed the transfer of basic science to the applied arena, from bench to bedside. These attributions are reflected in the careers of this group of senior scientists. Now aging, some of this cohort have excelled in one or more of these areas of excellence. A smaller number have made their mark in all of the above. This is the category that represents the contributions by Ralph Bradshaw, for which we owe a significant debt of gratitude and admiration.
拉尔夫·布拉德肖,一位睿智的同事、企业家、天才编辑和有先见之明的科学家,最近辞去了FASEB BioAdvances的主编职务。这为我们提供了一个机会,让我们停下来反思一位杰出人士的职业生涯,他对科学、科学出版以及代表和倡导我们所有人的学术团体的持续承诺,说明了他的卓越。拉尔夫的职业生涯反映了对我们所有人努力实现的目标的不屈不挠的奉献-高标准的奖学金,领导能力,服务和创业精神。拉尔夫在波士顿地区长大,就读于科尔比学院,主修化学;他在杜克大学生物化学系和罗伯特·希尔一起完成了博士学位,他的论文主要研究蛋白质化学。他在印第安纳大学Frank Gurd实验室和华盛顿大学Hans Neurath实验室的博士后工作使他能够完善他的蛋白质测序和分析方法。P. Roy Vagelos(默克公司前首席执行官和华盛顿大学前系主任)将Ralph招募到华盛顿大学生物化学系,在Carl Cori的长期统治之后,Roy开始对该系进行非常成功的改造和重建。这是我第一次见到拉尔夫的地方,当时我们分别被任命为生物化学和生理学的助理教授,我们对研究生教育有着共同的兴趣。1973年,瓦格洛斯和他在华盛顿大学的同事们提出了一种新的生物和生物医学科学研究生教育方法,即生物和生物医学科学部(DBBS)——最近被命名为罗伊和戴安娜瓦格洛斯生物和生物医学科学部。这个想法是基于医学和生物研究的不断多样化,在这些研究中,分隔不同“研究领域”的传统部门界限越来越被视为压制创新和减少研究生研究机会的顽固筒仓。通过建立基于教师共同兴趣而不是部门隶属关系的项目,研究生研究的跨学科机会蓬勃发展——这种或那种形式的方法现在几乎在所有研究机构中都很常见。拉尔夫·布拉德肖(Ralph Bradshaw)在DBBS的起步过程中发挥了关键作用——也许这是他现在备受赞赏的组织能力的先驱。他被任命为新成立的研究生招生委员会的首任主席,热情地为这些项目招募有才华的学生,并在这个新保护伞下担任NIH首批培训补助金之一的首席研究员。罗伊·瓦格洛斯评论说:“布拉德肖是一位热情而高效的华盛顿大学研究生招聘人员。当DBBS的教职员工决定大学应该在研究生中有更大的多样性时,拉尔夫带领一小群教职员工访问了历史上的黑人学院,招募优秀的学生加入华盛顿大学的研究生项目。”拉尔夫过去和现在都是一个根深蒂固的数据保存者,以及数据是如何组织的,是一个Excel表格的主人。从澳大利亚休假回来后不久,拉尔夫在家里的书房里组装了一幅拼贴画,我们在那里接待了有抱负的申请者。这幅拼贴画包括了他旅行中整齐排列的几十件大事记。我刚从英国旅行回来,口袋里有一张火车票存根,我开玩笑地把它塞到了拉尔夫的一件拼贴画后面。你不知道吗,第二天早上第一件事就是我接到一个电话:“斯塔尔,你为什么要乱动我的(哔哔声)板子?”显然,这个人对秩序的关注贯穿了他的一生,他收集的各种书籍和纪念品,贯穿了他的研究和编辑工作。拉尔夫一直是一个“包容者”,努力提高历史上被排斥群体的代表性,将科学家聚集在一起,以加强合作,担任多个科学协会和组织的官员。以下是Amy Bradshaw(南卡罗来纳医科大学细胞生物学教授)的一句话:“在成长过程中,我们家有很多来自世界各地的访客,这让我看到并欣赏不同视角的奇迹——这是我父母强化和实践的理想。我有一个美好的童年记忆,那就是我们每年的感恩节大餐。在拉尔夫和佩妮家,我们经常举行大型聚会。由于这个部门的许多人都是国际人士,经常有客人从未听说过感恩节,或者对这个美国传统只有一个模糊的概念。我妈妈会做一只巨大的火鸡,每个人都会从世界各地带菜来完成这顿饭。 Ken Thomas (Trefoil Therapeutics的联合创始人和顾问,San Diego, CA, USA)写道:“除了Ralph的众多学术成就和贡献外,他还积极参与应用他在蛋白质生物化学方面的广泛科学专业知识和观点,担任工业顾问和企业科学顾问委员会成员,其中许多他担任主席。值得注意的是,他最近还与他以前的三名学生共同创立了几家公司,其中包括临床阶段的生物技术公司Trefoil Therapeutics,该公司是在他的实验室发现蛋白质生长因子FGF-1的早期工作中诞生的。拉尔夫一直密切参与三叶草的发展,担任首席科学官,目前担任科学顾问委员会主席。他以正直、知识渊博的洞察力和热情对待这些创业活动,使与他一起工作成为一种持续的有益和愉快的经历,不仅是作为共同创始人,也是作为独立的科学合作者,最初是博士后。”拉尔夫·布拉德肖,科学家、教师、编辑和企业家,是一群在20世纪60年代接受教育,在20世纪70年代进入学术界的个人、科学家和医生科学家中的一员,他们帮助改变和推进了美国生命科学,使其达到即使是最乐观的观察者也无法预料的水平。这群人为研究生教育和医学教育做出了贡献和支持;它们是扩展我们对细胞和生物体中分子过程的基本理解的关键驱动力;它们对将科学家及其社区与公众联系起来的传播质量和方式作出了广泛贡献;他们催化了基础科学向应用领域的转移,从实验室到病床。这些归因反映在这群资深科学家的职业生涯中。随着年龄的增长,这批人中的一些人在一个或多个领域表现出色。少数人在上述所有方面都取得了成就。这一类代表了拉尔夫·布拉德肖的贡献,我们对此深表感激和钦佩。